These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo. Mayr FB; Knöbl P; Jilma B; Siller-Matula JM; Wagner PG; Schaub RG; Gilbert JC; Jilma-Stohlawetz P Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617 [TBL] [Abstract][Full Text] [Related]
4. Molecular genetics of von Willebrand disease. Mazurier C; Ribba AS; Gaucher C; Meyer D Ann Genet; 1998; 41(1):34-43. PubMed ID: 9599650 [TBL] [Abstract][Full Text] [Related]
5. A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow. Galbusera M; Remuzzi A; Benigni A; Rossi C; Remuzzi G Am J Kidney Dis; 2000 Oct; 36(4):695-702. PubMed ID: 11007670 [TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor in the pathophysiology of thrombotic thrombocytopenic purpura. Moake JL Clin Lab Sci; 1998; 11(6):362-4. PubMed ID: 10345504 [TBL] [Abstract][Full Text] [Related]
7. [Multimeric composition of von Willebrand factor in thrombotic thrombocytopenic purpura. Japanese TTP Study Group]. Tatewaki W Nihon Rinsho; 1993 Jan; 51(1):146-50. PubMed ID: 8433508 [TBL] [Abstract][Full Text] [Related]
8. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura. Moore JC; Murphy WG; Kelton JG Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725 [TBL] [Abstract][Full Text] [Related]
9. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor. Kumar RA; Moake JL; Nolasco L; Bergeron AL; Sun C; Dong JF; McIntire LV Biorheology; 2006; 43(5):681-91. PubMed ID: 17047284 [TBL] [Abstract][Full Text] [Related]
10. Abnormalities of von Willebrand factor multimers in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. Moake JL; McPherson PD Am J Med; 1989 Sep; 87(3N):9N-15N. PubMed ID: 2486537 [TBL] [Abstract][Full Text] [Related]
11. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease. Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura. Jilma-Stohlawetz P; Gorczyca ME; Jilma B; Siller-Matula J; Gilbert JC; Knöbl P Thromb Haemost; 2011 Mar; 105(3):545-52. PubMed ID: 21174003 [TBL] [Abstract][Full Text] [Related]
14. Diagnosis and follow-up of thrombotic thrombocytopenic purpura by means of von Willebrand factor collagen binding assay. Casonato A; Fabris F; Pontara E; Cattini MG; Zocca N; Gallinaro L; Girolami A; Pagnan A Clin Appl Thromb Hemost; 2006 Jul; 12(3):296-304. PubMed ID: 16959682 [TBL] [Abstract][Full Text] [Related]
15. Indications for a protective function of beta2-glycoprotein I in thrombotic thrombocytopenic purpura. Du VX; van Os G; Kremer Hovinga JA; Dienava-Verdoold I; Wollersheim J; Ruggeri ZM; Fijnheer R; de Groot PG; de Laat B Br J Haematol; 2012 Oct; 159(1):94-103. PubMed ID: 22881339 [TBL] [Abstract][Full Text] [Related]
16. The role of von Willebrand factor (vWF) in thrombotic thrombocytopenic purpura (TTP) and the hemolytic-uremic syndrome (HUS). Moake JL Prog Clin Biol Res; 1990; 337():135-40. PubMed ID: 2191307 [No Abstract] [Full Text] [Related]
17. Binding of platelet agglutinating protein p37 from the plasma of a patient with thrombotic thrombocytopenic purpura to human platelets. Lian EC; Siddiqui FA Thromb Haemost; 1991 Jan; 65(1):96-101. PubMed ID: 2024244 [TBL] [Abstract][Full Text] [Related]
18. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura. Tsai HM; Rice L; Sarode R; Chow TW; Moake JL Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702 [TBL] [Abstract][Full Text] [Related]
19. Increased von Willebrand factor binding to platelets in single episode and recurrent types of thrombotic thrombocytopenic purpura. Chow TW; Turner NA; Chintagumpala M; McPherson PD; Nolasco LH; Rice L; Hellums JD; Moake JL Am J Hematol; 1998 Apr; 57(4):293-302. PubMed ID: 9544973 [TBL] [Abstract][Full Text] [Related]
20. [The changes in von Willebrand factor multimer in a course of thrombotic thrombocytopenic purpura]. Saitoh M; Wada H; Tanigawa M; Tamaki S; Masuya M; Minami N; Deguchi K; Shirakawa S; Tatewaki W; Takahashi H Rinsho Ketsueki; 1991 Sep; 32(9):1006-8. PubMed ID: 1942536 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]